Pembrolizumab and Cabozantinib in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma (RMHNSCC): 2-year Long Term Survival Update with Biomarker Analysis

被引：0
|
作者：
Saba, N. F. [1 ]
Ekpenyong, A. [1 ]
McCook, A. [1 ]
Schmitt, N. C. [1 ]
Gross, J. H. [1 ]
Rudra, S. F. [1 ]
Stokes, W. A. [2 ]
Kirtane, K. [3 ]
Chaudhary, R. [4 ]
Biernacki, M. [4 ]
Slebos, R. [4 ]
Song, X. [4 ]
Steuer, C. [5 ]
Shin, D. M. [5 ]
Teng, Y. F. [1 ]
Liu, Y. [6 ]
Chung, C. H. [3 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Emory Univ, Winship Canc Inst, Dept Radiat Oncol, Atlanta, GA 30322 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[4] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[5] Emory Univ, Winship Canc Inst, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA
[6] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 118卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2
引用
收藏
页码：E3 / E3
页数：1
相关论文
共 50 条
  • [41] Optimizing Treatment for Head and Neck Cancers: Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
    Haddad, Robert, I
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (07): : 982 - 984
  • [42] The emergence of long-term survivors in recurrent and metastatic squamous cell head and neck cancer
    Castet, Florian
    Brenes, Jesus
    Taberna, Miren
    Mesia, Ricard
    [J]. CURRENT OPINION IN ONCOLOGY, 2019, 31 (03) : 160 - 168
  • [43] Phase 2 study of dalantercept in recurrent or metastatic squamous cell carcinoma of the head and neck
    Jimeno, Antonio
    Posner, Marshall R.
    Weiss, Jared
    Wirth, Lori J.
    Saba, Nabil F.
    Cohen, Roger B.
    Popa, Elizabeta C.
    Argiris, Athanassios
    Grossmann, Kenneth F.
    Sukari, Ammar
    Korth, Chris
    Wilson, Dawn
    McClure, Ty
    Alimzhanov, Marat
    Pearsall, Scott
    Attie, Kenneth M.
    Sherman, Matthew L.
    Pandya, Shuchi Sumant
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Cost-Effectiveness Analysis Of Pembrolizumab In The Treatment Of Advanced Recurrent Metastatic Head And Neck Squamous Cell Carcinoma In China And The United States
    Liu, Maobai
    Han, Sijie
    Zheng, Bin
    Cai, Hongfu
    Yang, Jing
    Zhuang, Qian
    Li, Na
    [J]. CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 9483 - 9493
  • [45] Prognostic significance of metastatic sites in recurrent or metastatic squamous cell carcinoma of the head and neck
    Nishimura, Ari
    Yokota, Tomoya
    Iida, Yoshiyuki
    Kamijo, Tomoyuki
    Mukaigawa, Takashi
    Onozawa, Yusuke
    Todaka, Akiko
    Hamauchi, Satoshi
    Kawakami, Takeshi
    Shirasu, Hiromichi
    Onoe, Tsuyoshi
    Ogawa, Hirohumi
    Kawabata, Takanori
    Yasui, Hirofumi
    Onitsuka, Tetsuro
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S296 - S296
  • [46] Association of autoimmunity with survival in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab
    Economopoulou, Panagiota
    Kotsantis, Ioannis
    Papaxoinis, George
    Gavrielatou, Niki
    Anastasiou, Maria
    Pantazopoulos, Anastasios
    Kavourakis, George
    Gkolfinopoulos, Stavros
    Panayiotides, Ioannis
    Delides, Alexandros
    Psyrri, Amanda
    [J]. ORAL ONCOLOGY, 2020, 111
  • [47] Clinical Variables Associated with Survival and Treatment Response in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
    Haring, C. T.
    Kana, L.
    Dermody, S.
    Smith, J. D.
    Brenner, J. C.
    Casper, K.
    Chinn, S. B.
    Malloy, K.
    Mierzwa, M. L.
    Prince, M. E.
    Rosko, A. J.
    Schonewolf, C.
    Shah, J. L.
    Stucken, C. L.
    Shuman, A.
    Spector, M.
    Worden, F.
    Swiecicki, P. L.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 112 (05): : E44 - E44
  • [48] A phase 1 study of concurrent cabozantinib and cetuximab in recurrent or metastatic head and neck squamous cell cancer
    Desilets, Antoine
    Pfister, David G.
    Stein, Sarah
    Wong, Winston
    Sherman, Eric J.
    Fetten, James
    Hung, Tony K. W.
    Kriplani, Anuja
    Dunn, Lara A.
    Ho, Alan L.
    Michel, Loren S.
    [J]. ORAL ONCOLOGY, 2024, 154
  • [49] Emergence of long-term surviving patients with the introduction of Cetuximab in recurrent/metastatic disease of squamous cell carcinoma of head and neck
    Linares, Jenniffer
    Rullan, Antonio
    Taberna, Miren
    Vazquez, Silvia
    Mesia, Ricard
    [J]. ORAL ONCOLOGY, 2016, 55 : E4 - E4
  • [50] Apatinib for heavily pretreated recurrent and/or metastatic head and neck squamous cell carcinoma: Updated analysis
    Yang, K.
    Peng, G.
    Qin, Y.
    Huang, J.
    Ding, Q.
    Yang, Z.
    Dong, Y.
    Zhou, H.
    Cao, F.
    Chen, G.
    Zhu, L.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S808 - S808
12345